I know there are options out there like Paddle, FastSpring, and Lemon Squeezy that have worked for many apps like mine over the years. But I also wanted something simple for my users. Not to mention Apple Pay was a must-have.
I believe all the services he mentions do support Apple Pay.
RevenueCat serves as the source of truth for whether or not a customer is licensed.
I create RevenueCat customer IDs from local iCloud identifiers (more specifically, calling userRecordID() on my CKContainer in CloudKit).
When the user makes a purchase, they earn an entitlement that I look for in Arborist to grant them a license.
He doesn’t need to run his own server, and the purchases are automatically tied to the user’s iCloud account, so there are no e-mails or serial numbers to deal with. On the other hand, well, it’s all dependent on the Apple Account.
The app, which helps manage Git worktrees, is shipping now.
In Tower 15, we introduced the “Fully Merged” badge and Automatic Branch Management to help you keep your repository tidy. With Tower 17, we’re taking the detection behind that badge to a whole new level. […] Tower now matches your local branches against merged pull requests from your hosting service, such as GitHub or GitLab.
[…]
Trust is everything when deleting branches — so we redesigned the “Fully Merged” hint view to show you exactly which checks matched.
[…]
One that is particularly noteworthy is that updating submodules is now significantly faster! Tower gathers each submodule's Git data concurrently instead of one at a time—something you will especially notice in repositories with many submodules.
A team of neuroscientists has reported that deep brain stimulation (DBS) targeted to the motor thalamus can reshape how the brain controls both speech and swallowing—and crucially, that the outcome depends on stimulation frequency. The findings, from experiments reported in Nature Communications (2026), suggest that “tuning” DBS parameters may offer more refined control over complex, real-world behaviors than previously possible.
The study centers on motor-thalamus DBS, a strategy explored for movement disorders and related symptoms. Instead of treating stimulation as a single fixed setting, the researchers tested multiple frequencies and monitored changes in speech-related signals and swallowing performance. This frequency sensitivity points to circuit-level dynamics where different stimulation rates engage distinct neural processing modes.
In practical terms, the results imply that higher or lower frequencies may preferentially drive or suppress specific pathways that contribute to oral motor timing. Speech production relies on precisely coordinated patterns of muscle activation, airflow, and sensory feedback; swallowing requires rapid, sequence-based control to protect the airway. Alterations in these timing networks could explain why DBS can influence both functions simultaneously.
The authors describe the effects as frequency-dependent, meaning that the same DBS target produces divergent outcomes when the pulse rate changes. Such divergence is consistent with the idea that stimulation can shift synaptic interactions, firing synchrony, and network oscillations within the thalamocortical loop. When the stimulation rhythm matches intrinsic circuit oscillations, the brain may stabilize certain motor programs; at other rates, it may destabilize them.
Importantly, the work frames DBS not only as a way to modulate symptoms, but as a potential tool for “behavioral steering.” If translated to clinical settings, clinicians could adjust DBS frequency to reduce speech side effects while maintaining or improving swallowing safety, rather than relying on a one-size-fits-all configuration.
The study also highlights an often-overlooked challenge: therapies optimized for movement may inadvertently affect speech and swallowing, both of which share overlapping motor control resources. Frequency tuning could become a lever for mitigating such trade-offs, improving quality of life for patients who already depend on DBS.
While the research is mechanistic, its implications are immediately viral-science-worthy: the possibility that a single hardware intervention can be dynamically optimized for nuanced functions. The next step will be confirming how these frequency effects scale across different individuals and disease states.
As DBS devices become more programmable, the field is moving toward personalized stimulation “dial settings.” This report adds to that momentum by providing evidence that the motor thalamus does not respond uniformly—frequency matters, and the brain appears to treat different pulse rates as different control regimes.
Subject of Research: Deep brain stimulation (DBS) targeted to the motor thalamus and its frequency-dependent effects on speech and swallowing.
Article Title: Frequency-dependent effects of motor thalamus deep brain stimulation on speech and swallowing.
Article References: Tang, L.W., Grigsby, E.M., Damiani, A. et al. Frequency-dependent effects of motor thalamus deep brain stimulation on speech and swallowing. Nat Commun (2026). https://doi.org/10.1038/s41467-026-75588-3
O iPhone 17 Pro Max é o smartphone mais avançado da Apple! Na sua lista de especificações técnicas, podemos destacar a tela Super Retina XDR de 6,9 polegadas, o conjunto de três câmeras (com um sistema Fusion de 48 megapixels nas três lentes) e o processador A19 Pro, além da presença do Controle da Câmera (Camera Control) e do botão de Ação (Action Button).
Se levarmos em conta que o preço tabelado desse modelo aqui no Brasil é de R$13.999 nessa mesma modalidade de pagamento, estamos diante de um desconto de 23%.
Já para quem preferir pagar à vista (também no cartão de crédito), o preço fica ainda melhor: ele cai para R$9.752,31 — um desconto também de 23% em relação ao valor da Apple na mesma modalidade de pagamento, de R$12.599,10.
Todos os descontos de promoções divulgadas pelo MacMagazine são calculados com base nos preços sugeridos pela Apple ou por outras fabricantes. Pode ser que um determinado produto seja comumente encontrado por valores inferiores em redes varejistas, mas a nossa base de comparação é sempre em cima das tabelas oficiais.
Se você não é louco, é claro que gosta de economizar. E, para isso, o MacMagazine tem diversas opções para ajudar você a conseguir comprar o seu produto Apple pagando menos!
NOTA DE TRANSPARÊNCIA: O MacMagazine recebe uma pequena comissão sobre vendas concluídas por meio de links deste post, mas você, como consumidor, não paga nada mais pelos produtos/serviços usando os nossos links de afiliado.
O iPhone 17 recebeu várias melhorias em relação ao seu antecessor, o que fez dele o smartphone perfeito para a grande maioria dos usuários que procuram um telefone da Apple.
Entre as suas especificações técnicas, podemos destacar a tela Super Retina XDR de 6,3 polegadas com ProMotion (até 120Hz), o conjunto de duas câmeras (com um sistema Fusion de 48 megapixels nas duas lentes) e o processador A19, além da presença do Controle da Câmera (Camera Control) e do botão de Ação (Action Button).
Se levarmos em conta que o preço tabelado desse modelo aqui no Brasil é de R$7.999 nessa mesma modalidade de pagamento, estamos diante de um desconto de 26%.
Para chegar a esses valores, adicione o cupom SMART150 ao seu carrinho antes de concluir a compra.
Todos os descontos de promoções divulgadas pelo MacMagazine são calculados com base nos preços sugeridos pela Apple ou por outras fabricantes. Pode ser que um determinado produto seja comumente encontrado por valores inferiores em redes varejistas, mas a nossa base de comparação é sempre em cima das tabelas oficiais.
Se você não é louco, é claro que gosta de economizar. E, para isso, o MacMagazine tem diversas opções para ajudar você a conseguir comprar o seu produto Apple pagando menos!
NOTA DE TRANSPARÊNCIA: O MacMagazine recebe uma pequena comissão sobre vendas concluídas por meio de links deste post, mas você, como consumidor, não paga nada mais pelos produtos/serviços usando os nossos links de afiliado.
O iPhone 17 recebeu várias melhorias em relação ao seu antecessor, o que fez dele o smartphone perfeito para a grande maioria dos usuários que procura um telefone da Apple.
Entre as suas especificações técnicas, podemos destacar a tela Super Retina XDR de 6,3 polegadas com ProMotion (até 120Hz), o conjunto de duas câmeras (com um sistema Fusion de 48 megapixels nas duas lentes) e o processador A19, além da presença do Controle da Câmera (Camera Control) e do botão de Ação (Action Button).
Se levarmos em conta que o preço tabelado desse modelo aqui no Brasil é de R$9.499 nessa mesma modalidade de pagamento, estamos diante de um desconto de 25%.
Todos os descontos de promoções divulgadas pelo MacMagazine são calculados com base nos preços sugeridos pela Apple ou por outras fabricantes. Pode ser que um determinado produto seja comumente encontrado por valores inferiores em redes varejistas, mas a nossa base de comparação é sempre em cima das tabelas oficiais.
Se você não é louco, é claro que gosta de economizar. E, para isso, o MacMagazine tem diversas opções para ajudar você a conseguir comprar o seu produto Apple pagando menos!
NOTA DE TRANSPARÊNCIA: O MacMagazine recebe uma pequena comissão sobre vendas concluídas por meio de links deste post, mas você, como consumidor, não paga nada mais pelos produtos/serviços usando os nossos links de afiliado.
EU tech regulation, Digital Markets Act, Apple Europe sales, Apple regulation, European Union, Siri AI, iPhone features, device interoperability, App Store changes, alternative marketplaces, iPhone Mirroring, AirPods translation, Apple privacy, iPhone security, app sideloading, platform competition, DMA compliance, Apple Intelligence, European technology, government control
EU tech regulation is no longer limited to App Store payment rules or competition disputes hidden from ordinary consumers. It is beginning to determine which features reach European devices, how quickly they arrive and how deeply third-party companies can interact with the iPhone, iPad and Mac.
The Digital Markets Act was designed to reduce the control of large technology platforms over software distribution, payments, browsers, digital assistants and connected hardware. For Apple, compliance has already produced alternative app marketplaces, web distribution, third-party payment options, additional default-app controls and expanded access to iPhone technologies.
The next phase reaches much deeper into the operating system. European regulators want competing accessories, cloud services and AI assistants to receive access to capabilities traditionally reserved for Apple’s own products.
Apple argues that some of those demands could weaken privacy and security. The European Commission says the company is responsible for creating compliant systems that preserve both competition and user protection.
Between those positions sits a large and commercially significant group of customers. Europe generated $28.06 billion in Apple sales during the quarter ending March 28, 2026, up from $24.45 billion one year earlier. Six-month European sales reached $66.20 billion, compared with $58.32 billion during the same period of fiscal 2025.
Europe therefore represented more than one-quarter of Apple’s latest quarterly revenue. It is too valuable to leave behind, but increasingly difficult to serve with the same software experience available elsewhere.
EU Tech Regulation Is Splitting Feature Availability
Regional differences once centered mainly on language support, licensing agreements or local services. EU tech regulation is creating a more structural divide.
Apple has blamed Digital Markets Act requirements for delaying Siri AI across the European Union. The company says regulators expect competing AI assistants to receive extensive access to personal information, apps and device actions before Apple can reserve those capabilities for its own assistant.
The disagreement concerns more than answering questions. Siri AI is designed to read personal context, understand onscreen information and complete actions across apps. That may include finding messages, accessing files, making purchases or sending information on the user’s behalf.
Opening those capabilities to outside AI systems requires new permission structures, technical interfaces and safeguards. Apple says it cannot release its assistant first and add competing access later without risking regulatory action. The Commission says Apple had sufficient time to design an interoperable solution.
Other delayed European features have included iPhone Mirroring on Mac, Live Translation through AirPods and certain location-based Maps capabilities. Each feature touches a different part of the ecosystem, but all depend on privileged communication between Apple devices, software and services.
The consequence is becoming visible at purchase. Two customers can buy the same iPhone model at similar prices and receive different capabilities because one lives inside the European Union.
Image Credit: Apple Inc.
Feature Adoption Becomes Slower and Less Predictable
Delayed availability can weaken the adoption of new hardware features even when the devices themselves continue selling well.
Siri AI is intended to become a central part of newer iPhones, iPads and Macs. Buyers who cannot access it lose part of the justification for newer chips, additional memory and on-device AI processing. Developers also face a smaller addressable audience for apps built around the new assistant.
AirPods Live Translation presents a similar problem. A feature designed to demonstrate the combination of iPhone processing, microphones and wearable audio becomes unavailable in a region built around dozens of languages and frequent cross-border travel.
iPhone Mirroring affects the relationship between iPhone and Mac. Users outside the EU can interact with the phone from macOS, while European users may receive notifications without gaining the complete experience.
These differences do not necessarily stop hardware sales. Apple’s newest results show strong European demand despite years of regulatory conflict. They can, however, reduce the speed at which customers use the ecosystem’s newest capabilities.
The effect may grow as software becomes a larger part of hardware differentiation. A faster processor has limited emotional value when the feature designed to demonstrate it is unavailable.
Apple Sales Show Why Europe Cannot Be Ignored
Apple does not report European Union revenue separately. Its Europe segment also includes countries outside the bloc, along with India, the Middle East and Africa. The official segment remains the best regularly published measure of the region’s commercial weight.
European sales rose approximately 15% year over year in Apple’s latest reported quarter. During the first six months of fiscal 2026, the segment expanded by roughly 14%.
Those figures weaken the argument that regulation is already driving customers away from Apple hardware. Demand remains strong, supported by the iPhone 17 family, Mac sales, services and the company’s installed base.
The financial risk is more gradual. Regional software fragmentation can raise engineering costs, delay launches and make European devices less competitive against products able to offer complete feature sets.
Apple must maintain separate distribution rules, payment systems, browser options and eligibility checks. Developers must decide whether alternative stores, external payments or EU-specific business terms justify additional work. Support teams must explain why features differ between countries using the same operating-system version.
A market responsible for more than $28 billion in one quarter can absorb considerable compliance expense. It can also influence Apple’s global product decisions when regulators demand interfaces that cannot be restricted to Europe easily.
A Slow Transfer of Ecosystem Control
The escalating regulatory environment also creates a more fundamental concern: control over complex technology ecosystems can gradually move away from the companies that designed them and toward government committees, regulatory bodies and administrative processes.
That transfer rarely happens through one dramatic order. It develops through repeated obligations covering app distribution, payment systems, browser engines, digital assistants, hardware access, data portability and interoperability. Each requirement may appear narrow when considered alone. Together, they can redefine who determines how the ecosystem operates.
Apple built its platform around tight integration between hardware, software, services and security. Regulators increasingly treat parts of that integration as market power that must be opened to competitors. The danger is that an ecosystem designed as one coordinated environment becomes subject to decisions made by committees that do not carry direct responsibility for product quality, reliability or long-term maintenance.
This can become a slow trap. Once a platform is required to expose one layer, regulators may use that access as the basis for demanding another. A payment exception can be followed by alternative app stores. Alternative stores can lead to broader installation rights. Device interoperability can expand into access for AI assistants, personal data and system actions.
The boundaries of the platform are then set less by engineering judgment and more by regulatory negotiation.
Government agencies have legitimate authority to address competition and consumer harm. The concern appears when regulation shifts from preventing abusive conduct to directing product architecture. At that point, public authorities begin influencing feature design, release timing, software permissions and the relationship between first-party and third-party services.
That creates consequences beyond Apple. Any company considering a tightly integrated product may decide that deep integration invites intervention. Businesses could avoid building ambitious ecosystems if successful coordination later becomes grounds for forced access.
Innovation then becomes shaped by what regulators are likely to permit rather than by what engineers believe will produce the safest or most coherent experience.
Image Credit: Ink Drop / Alamy Stock Photo
Competition Gains Come With Real Consumer Choices
EU policy has produced benefits that Apple rarely emphasizes. Users can install apps through alternative marketplaces or directly from authorized developers. Developers can offer external payment methods, promote different prices and avoid relying entirely on Apple’s distribution system.
Alternative browser engines can compete with WebKit, while users have more control over default apps. Contactless payment access has expanded beyond Apple Pay, allowing competing wallet providers to use the iPhone’s NFC technology under approved conditions.
Interoperability requirements could also improve third-party accessories. Smartwatches, headphones and other devices may gain better notification access, background connectivity and proximity pairing with the iPhone.
These changes can increase competition and reduce the advantage Apple gives its own services and accessories. A third-party smartwatch should not become artificially less useful simply because it was not made in Cupertino.
The difficulty is separating legitimate platform access from unlimited access. A notification interface is one thing. An autonomous AI assistant capable of reading messages, accessing files and acting across apps introduces a different level of sensitivity.
Privacy and Security Risks Are Not Theoretical
Alternative app distribution increases user choice, but it also moves some responsibility away from the App Store. Apple continues to notarize apps distributed through approved alternative channels, checking for known malware and severe fraud. That process is narrower than a complete App Store review.
Purchases made outside Apple’s payment system also fall outside its normal refund and billing support. Users may need to resolve disputes directly with the developer or payment provider.
A malicious marketplace, deceptive payment page or compromised developer account can create opportunities for fraud. Enterprise users face additional concerns when employees install software from sources their organization has not approved.
The AI question reaches further. A third-party assistant may need permission to access messages, photos, calendars, documents and app controls. Even a reputable provider can collect more information than the user expects or introduce vulnerabilities through poorly designed integrations.
Apple can build permission prompts, app isolation and revocation controls, but technical access always creates some exposure. Security depends on how narrowly permissions are defined, how visibly they are used and whether the operating system can stop unauthorized actions.
The Commission maintains that interoperability and privacy can coexist. Apple maintains that regulators are demanding access before adequate protections are ready. Both positions contain a legitimate concern: dominant platforms should not block competition, and competition should not require users to surrender control of personal data.
When regulators require a company to alter its architecture, responsibility can become blurred.
Apple remains the company customers blame when an iPhone feature fails, a third-party marketplace distributes a harmful app or an outside assistant misuses personal data. Regulators may have required the access, but they do not operate the device, provide technical support or repair the damage to the platform’s reputation.
This creates an accountability gap. Government committees can mandate openness without assuming the commercial and security consequences of that openness. Apple must comply, maintain the system and explain the outcome to users.
The same problem applies to delayed features. Regulators may argue that Apple chose not to release a service, while Apple may argue that the required conditions made the launch unsafe or technically impractical. Customers are left with less functionality and no simple way to determine who caused the delay.
Over time, the ecosystem can become a negotiated compromise rather than a product with one coherent direction. That may satisfy formal compliance while producing a weaker experience for everyone involved.
The risk is not that governments will literally operate Apple’s software. It is that committees increasingly define the conditions under which Apple can design, connect and release its own features. Control shifts through constraints.
The Industry Will Follow Europe’s Experiment
The consequences extend beyond one company. Google, Meta, Microsoft, Amazon and other platform operators face related European obligations. Hardware makers must consider whether ecosystem advantages can survive when core services are required to support rivals.
Smaller developers may gain new distribution and payment choices, but they may also inherit more compliance, customer-service and security responsibilities. Accessory companies could compete more effectively while becoming accountable for handling sensitive device data.
Other governments are watching. Rules introduced in Europe can influence legislation elsewhere, particularly when companies decide that maintaining one global technical framework is easier than operating several regional versions.
Apple is unlikely to abandon Europe or stop adapting its products. Its sales provide too much evidence of the region’s importance. The company will continue negotiating, appealing decisions and building compliance systems while withholding features it considers unsafe under current demands.
European customers may receive more app stores, payment choices and accessory compatibility. They may also wait longer for headline features included with the same hardware elsewhere.
The deeper consequence may be a technology industry that becomes more cautious about building tightly integrated products. Companies may design around anticipated regulatory demands from the beginning, limiting exclusive features, reducing private-system integration or avoiding innovations that depend on controlled access.
EU tech regulation began as an effort to constrain dominant platforms. Its long-term effect may be to transfer part of the power to shape those platforms from companies and users to regulatory institutions.
That shift deserves scrutiny equal to the market power it is intended to correct. Competition rules can restrain abuse. They can also become a slow mechanism for placing product design, security choices and ecosystem evolution under government supervision.
Shady Control and Bureaucracy
The danger grows when regulatory discretion becomes buried beneath permits, approvals, negotiations and technical committees that operate beyond meaningful public scrutiny.
The more power officials hold over which features, contracts or technologies may proceed—and when—the greater the opportunity for lobbying, favoritism and selective enforcement to influence outcomes. What begins as oversight can gradually become a system in which delay itself is leverage, while responsibility disappears inside layers of administration.
For the technology industry, that risks replacing transparent product decisions with political access, negotiated exceptions and regulatory influence exercised far from the consumers expected to live with the consequences.
Some gun violence experts are skeptical. But the research raises questions of whether there’s a cause-and-effect relationship and if so, what’s behind it.
Passkeys have been around for some time, but enterprise-wide adoption to this point has been slow for a number of reasons. But soon, many Microsoft customers won’t have a choice.
Starting September 1, Microsoft will roll out passkeys as the default authentication method in its cloud-based identity and access management (IAM) service Entra ID. And following a transition period, Microsoft-provided SMS and voice authentication will officially end on February 1, 2027.
With this move, Microsoft seems to be underlining the urgent need for a more secure authentication standard, as attackers up their game with AI.
This is an “important milestone,” because it moves passwordless authentication from an optional security enhancement to the expected standard, noted Ensar Seker, CISO at SOCRadar. “That shift is significant as attackers increasingly rely on AI to automate phishing campaigns, generate convincing login pages, and conduct large-scale credential theft.”
Microsoft’s six-month passkey roll-out
Passkeys require users to authenticate via a fingerprint, facial scan, or lock screen mechanism, rather than a password. They can be stored on physical USB keys (like YubiKey), or as digital credentials on computers, phones, or in cloud accounts.
This method, Microsoft contended, reduces reliance on phishable authentication tools like SMS and voice, and hardens protection against credential theft.
Passkeys “work better for users and worse for cyberattackers,” Nadim Abdo, Microsoft corporate VP for identity and network access engineering, wrote in a blog post.
Microsoft’s announced timeline for rolling out passkeys is relatively aggressive:
September 1, 2026: All SMS or voice-enabled users will be “auto-enabled and nudged” to register a passkey upon multifactor authentication (MFA) sign-in.
September 18, 2026: Pricing, commercial terms, and a list of supported telecom providers will be shared for scenarios that still require SMS or voice authentication due to regulation or technical or operational challenges.
October 30, 2026: Enterprises still using SMS and voice must select and configure a supported telecom provider through the Microsoft Security Store. From then on, they will be responsible for any telecom-related costs.
February 1, 2027: Microsoft-provided telecom delivery for SMS and voice authentication ends as a native Microsoft Entra capability.
After February 1, enterprises that require SMS or voice for MFA must register a passkey before sign-in. There will be no opt-out option.
It’s important to note that these dates apply to public cloud-hosted Entra ID. Support for other cloud environments will follow a separate timeline; additional guidance and dates are to come.
While SMS and voice have served their purpose well, Abdo said, bringing MFA to billions of users who otherwise would have had none, the threat environment has changed in “speed, scale, and sophistication,” necessitating this move to passkeys.
The benefits of passkeys
SOCRadar’s Seker pointed out that passkeys fundamentally change the attack surface because, unlike with passwords, there is no transmission of shared secrets that can be stolen by threat actors. Authentication requires possession of the user’s device, along with biometric verification or a PIN.
“Even highly convincing AI-generated phishing pages cannot simply trick users into handing over a passkey the way they can with passwords or one-time codes,” he said.
So why haven’t we seen widespread enterprise adoption? Identity ecosystems are “fragmented,” Seker noted, and many enterprises still rely on legacy applications that only support passwords. They also struggle with cross-platform compatibility, lifecycle management, recovery processes, shared accounts, and employee onboarding and offboarding.
Further, “until recently, many organizations viewed passkeys as a consumer technology rather than an enterprise identity strategy,” he said.
Microsoft’s move changes that equation, because Entra sits at the center of many organizations’ identity infrastructure, Seker noted. Default settings are typically the strongest drivers of security adoption, so when passwordless authentication becomes required rather than optional, organizations are far more likely to deploy it at scale.
Its biggest benefit would be a “dramatic reduction” in credential-based attacks, Seker said. He pointed out that most successful compromises still begin with stolen credentials obtained through phishing, infostealer malware, password reuse, or adversary-in-the-middle attacks. Passkeys “eliminate or significantly reduce” many of those attack paths, while reducing password fatigue and the help desk costs related to password resets.
In addition, rather than trying to continuously improve users’ ability to detect increasingly sophisticated phishing attempts, passkeys remove the credential from the equation altogether, Seker noted. “That represents a more sustainable long-term security strategy than relying solely on user awareness training.”
Still, passkeys are not a silver bullet, as they do not stop endpoint compromise, session token theft, malicious insiders, or attackers who already have control of a trusted device. Enterprises must complement passkeys with endpoint protection, continuous monitoring, conditional access policies, and identity threat detection, Seker advised.
How enterprises can prepare
To prepare for the shift to passkeys, Microsoft advised enterprises to review their authentication policy and identify the groups still using SMS or voice authentication. They should then select the best authentication method for user devices and workflows, and ensure all employees are given passkeys and security keys.
Entra ID supports both synced passkeys (those stored in platform credential managers like iCloud Keychain and Google Password Manager), and device-bound passkeys such as Microsoft Authenticator passkeys, Entra passkey on Windows, or FIDO2 security keys.
Seker advised enterprises to evaluate support for FIDO2 and passkeys across their identity infrastructure, and to develop clear enrollment and recovery procedures. They should also educate users on what’s changing, how passkeys work, and how they can complete registration. Further, Seker said, it’s important to establish secure device management practices and to continue enforcing least privilege, conditional access, and risk-based authentication policies throughout the transition.
Ultimately, he pointed out, the move is crucial. “Over the next several years, organizations that continue relying primarily on passwords will likely face higher operational risk as AI continues to lower the cost and increase the effectiveness of credential-based attacks,” he said.
In a groundbreaking stride toward the future of quantum technology, researchers have unlocked a new mechanism to control quantum emitters embedded in hexagonal boron nitride (hBN), a layered two-dimensional material. This breakthrough could serve as a critical leap forward in integrating quantum emitters into practical devices, bringing quantum computing, secure quantum communications, and ultra-sensitive quantum sensors closer to reality. This promising development emerged from meticulous experimental studies demonstrating the ability to reversibly tune the color and wavelength of light emitted by quantum defects in hBN simply by twisting its atomic layers.
Quantum emitters are nanoscopic sources of light that emit photons with quantum characteristics, pivotal for next-generation technologies reliant on quantum information processing. However, a formidable challenge in utilizing these emitters has been the difficulty in precisely controlling their optical properties post-fabrication. Dr. Angus Gale, the lead scientist behind this research, elucidated how their work provides an innovative “lever” by exploiting the intrinsic layered nature of hBN to adjust the quantum emission properties dynamically. Unlike traditional solid-state hosts such as diamond or silicon carbide, whose structures are rigid and three-dimensional, hBN’s atomically thin layers can be mechanically manipulated, lending itself to an unprecedented degree of tunability.
The team’s experiments demonstrated that by picking up, stacking, twisting, and restacking these ultra-thin hBN slices at varied angles, they could modulate the quantum emitters’ light emission dramatically. These shifts in wavelength were not minor perturbations but substantial changes far exceeding what has been typically achievable in similar solid-state quantum systems. This finding challenges the traditional paradigm which often seeks to stabilize quantum defect behavior within rigid host materials. Instead, the researchers embraced the inherent flexibility and twistability of hBN to realize a new class of quantum control.
Professor Igor Aharonovich, the supervising author, emphasized the broader implications of this twist-controlled modulation approach. He noted that coupling two-dimensional materials at specific twist angles opens up an entirely fresh set of physical phenomena that were previously inaccessible. By assembling layers with precision angular misalignment, new quantum states can emerge, potentially transforming the landscape of material engineering for quantum applications. This strategic layering and twisting, known as “twistronics,” has already inspired revolutionary advances in graphene-based systems, yet this study extends the concept into the realm of quantum emitters embedded in hBN.
One key advantage of using hBN is that its layered crystal structure allows researchers to systematically alter the interaction between layers, effectively tuning the electronic environment surrounding the defects responsible for quantum light emission. As Dr. Gale metaphorically illustrated, far from being a solid block, hBN behaves more like a stack of cheese slices. Just as peeling and recombining slices of cheese can change how flavors intermingle, twisting hBN slices changes the interaction between atomic planes, which in turn alters quantum emitter characteristics. This mechanical engineering at the nanoscale provides a versatile platform for on-demand tuning of quantum light sources.
This technology breakthrough is fundamentally experimental but holds widespread implications. Adjustable quantum emitters could accelerate the development of quantum computing hardware, where precise photon control is essential for encoding and manipulating qubits. Similarly, secure quantum communication protocols rely on tailored quantum light sources to guarantee the generation and distribution of entangled photons immune to interception. Moreover, quantum sensing that exploits the extreme sensitivity of quantum states to environmental changes stands to benefit significantly from tunable quantum emitters, pushing the boundaries of detection limits in fields ranging from medicine to navigation.
Another remarkable facet of the research is the ability to repeatedly pick up, twist, and restack hBN layers without degrading the quantum emitter properties. This reversibility enables iterative fine-tuning of device characteristics and might yield adaptable quantum systems reconfigurable post-production, a feature highly desirable from a technological deployment perspective. This contrasts sharply with permanent structural modifications used in conventional quantum emitter fabrication, which restrict adjustable control and device flexibility.
The team’s methodology involved sophisticated nanofabrication techniques and high-resolution optical spectroscopy to probe the quantum emitters’ response to twist-induced modifications. By correlating the angular misalignment with spectral shifts in emitted light, they constructed a detailed understanding of the underlying physics governing emission control. These insights provide a blueprint for engineering tailored quantum emitters with bespoke characteristics suitable for specific applications.
The research findings have been detailed in a paper published in the eminent journal Science Advances, signaling the scientific community’s enthusiasm for the potential unlocked by twistable quantum systems. Importantly, the authors have declared no competing interests, affirming the independent and foundational nature of this inquiry. Funded by the Australian Research Council and the Air Force Office of Scientific Research, the work highlights the vibrant collaboration between academic institutions and funding bodies committed to propelling quantum technologies.
This discovery heralds a new era in quantum material science, where layered two-dimensional crystals are no longer passive hosts but active tunable platforms. By harnessing the mechanical and electronic versatility of materials like hBN, researchers are gradually unlocking complex quantum phenomena with precision control previously deemed unachievable. The implications extend well beyond fundamental research, marking exciting progress toward quantum devices that could redefine computational power, information security, and sensory precision globally.
In summary, the twist-controlled modulation of quantum emitters in hexagonal boron nitride exemplifies the convergence of cutting-edge experimental physics and materials science innovation. By capitalizing on the unique layered architecture of hBN and the emerging discipline of twistronics, this research pioneers functional tunability in quantum light sources. As the scientific community continues to develop and refine these approaches, we edge closer to the practical implementation of quantum technologies that promise profound societal and technological transformation.
Subject of Research: Not applicable
Article Title: Twist-controlled modulation of quantum emitters in hexagonal boron nitride
Atherosclerosis remains the foremost cause of cardiovascular disease-related morbidity and mortality globally, posing a substantial challenge to healthcare systems. Although traditional risk factors such as diet, lifestyle, and genetics have been extensively studied, recent advances have illuminated the pivotal role played by epigenetic mechanisms in shaping the onset and progression of atherosclerotic disease. Epigenetics, the reversible modulation of gene expression without alterations to the DNA sequence, encompasses DNA methylation, histone modifications, and non-coding RNAs, all of which intricately orchestrate cellular behavior within vascular tissues.
Emerging research reveals that DNA methylation patterns, both globally across the genome and in gene-specific loci, critically regulate cellular proliferation and inflammatory responses integral to atherogenesis. Hypomethylation or hypermethylation at particular sites can drastically affect the transcriptional activity of genes responsible for maintaining vascular homeostasis. This phenomenon underscores a dynamic regulatory system where environmental cues and pathological stimuli can induce lasting epigenomic changes that propagate vascular dysfunction and inflammation.
Histone post-translational modifications add another sophisticated layer to this epigenetic landscape. Primarily involving acetylation and methylation of histone proteins, these modifications influence chromatin structure and, consequently, gene accessibility. Within atherosclerotic plaques, histone modifications have been shown to govern networks of genes related to lipid metabolism, cellular plasticity, and inflammatory signaling. Such modifications enable vascular cells to adapt to inflammatory and metabolic stress by modulating transcriptional programs essential for plaque development and instability.
Non-coding RNAs have further expanded the complexity of epigenetic regulation within the vascular milieu. Long non-coding RNAs (lncRNAs) shape the transcriptomic profiles of specific cell types and exert control over the localization and activity of epigenetic enzymes. This targeting ensures that epigenetic remodeling is not only precise but also tailored to cellular needs in the context of vascular remodeling. Concurrently, microRNAs (miRNAs), small regulatory RNAs, predominantly mediate post-transcriptional gene silencing but have been identified to participate in non-canonical functions that influence vascular cell phenotype and immune responses.
The integration of multi-omics approaches, combining epigenomics, transcriptomics, and proteomics, has revolutionized our understanding of the cell-specific epigenetic contributions in atherosclerosis. These technological advancements enable the dissection of complex intercellular interactions within plaques and facilitate the mapping of genetically associated loci to discrete epigenetic modifications. This multidimensional insight is vital to unraveling the heterogeneity of atherosclerotic lesions and their diverse clinical manifestations.
In vascular endothelial cells, epigenetic alterations modulate barrier function, inflammation, and response to shear stress, all of which are critical in the initial stages of atherogenesis. Endothelial dysfunction triggered by epigenetic dysregulation sets the stage for immune cell recruitment and plaque formation. Meanwhile, vascular smooth muscle cells (VSMCs) exhibit remarkable plasticity through epigenetic reprogramming that drives their phenotypic switch from a contractile to a synthetic state, facilitating extracellular matrix remodeling and plaque stability or vulnerability.
Immune cells within the atherosclerotic microenvironment are also subject to profound epigenetic modulation. Macrophages, T cells, and other leukocytes display distinct epigenetic signatures that influence their activation states and inflammatory profiles. Epigenetic memory within these immune populations can perpetuate chronic vascular inflammation, underscoring the need for targeted interventions that modulate immune cell epigenomes to mitigate atherosclerotic progression.
Preclinical studies have leveraged these mechanistic insights to explore epigenetic drug candidates capable of attenuating plaque burden and vascular inflammation. Histone deacetylase inhibitors, DNA methylation modulators, and RNA-based therapeutics have demonstrated efficacy in experimental models, highlighting their potential to recalibrate aberrant gene expression patterns driving disease. However, challenges remain in achieving cell-type specificity, minimizing off-target effects, and ensuring the durability and safety of such interventions in humans.
A critical hurdle for translational success lies in the delivery mechanisms for epigenetic therapies. Nanoparticle-based systems and ligand-targeted delivery platforms are under investigation to enhance precision targeting of vascular and immune cells within plaques. These delivery technologies aim to maximize therapeutic benefit while circumventing systemic toxicity, thereby advancing the clinical applicability of epigenetic modulators.
Long-term safety is another paramount consideration as epigenetic drugs inherently affect gene regulation, potentially leading to unforeseen consequences. Rigorous preclinical evaluation and carefully designed clinical trials are imperative to balance efficacy with safety, ensuring that epigenetic therapies can be integrated into cardiovascular medicine without triggering deleterious off-target effects.
The prospect of leveraging epigenetic regulation heralds a transformative shift in cardiovascular therapeutics, enabling precision medicine tailored to an individual’s unique epigenomic landscape. By elucidating the dynamic and reversible nature of epigenetic modifications in vascular cells and immune populations, researchers are charting new pathways to mitigate atherosclerosis beyond conventional lipid-lowering and anti-inflammatory strategies.
Continued exploration into the interplay between genetic predisposition and environmental influences mediated by epigenetic mechanisms promises to deepen our understanding of atherosclerosis pathobiology. This holistic view integrates molecular, cellular, and systemic insights, empowering the development of sophisticated therapeutics capable of interrupting the disease process at its regulatory roots.
In summary, the frontier of atherosclerosis research lies at the intersection of epigenetics and vascular biology. The potential to manipulate gene expression programs with high specificity and reversibility offers an unprecedented opportunity to combat the global burden of cardiovascular disease. As the field advances, collaboration across disciplines and innovative technological approaches will be essential to realize the therapeutic promise of epigenetic modulation in clinical practice.
With ongoing efforts focused on unraveling cell-specific epigenetic mechanisms, refining drug delivery technologies, and ensuring long-term treatment safety, the era of epigenetics-driven precision cardiology is on the horizon. This paradigm shift not only holds the key to diminishing the impact of atherosclerosis but also exemplifies the broader potential of epigenetic therapies across complex diseases.
Subject of Research: Epigenetic regulation mechanisms in atherosclerosis and their potential for therapeutic intervention.
Article Title: Epigenetic regulation in atherosclerosis and its therapeutic potential
Article References:
Santovito, D., Atzler, D. & Weber, C. Epigenetic regulation in atherosclerosis and its therapeutic potential. Nat Rev Cardiol (2026). https://doi.org/10.1038/s41569-026-01313-8
Physical therapy for stroke survivors has long relied on the physical presence and hands-on expertise of therapists walking alongside their patients. Now, a remarkable technological leap is reshaping this dynamic. Researchers at Northwestern University in collaboration with Shirley Ryan AbilityLab have unveiled a revolutionary rehabilitation system that forges a direct, real-time link between therapists and patients via robotic exoskeletons. This novel system, known as Therapist-Exoskeleton-Patient Interaction (TEPI), ushers in a new era of highly adaptive, personalized post-stroke gait therapy.
At the heart of TEPI lies a pair of lower-limb exoskeletons worn by the therapist and the stroke survivor, virtually coupled at the hips and knees through a sophisticated control interface. The virtual connection mimics the behavior of springs and shock absorbers, dynamically transmitting forces and movements between the two exoskeletons. This bidirectional, compliant coupling enables therapists to intuitively influence patient gait patterns in real time, offering a level of interaction that is vastly more nuanced than conventional robotic or manual therapies.
Traditional stroke rehabilitation often involves therapists physically assisting patients through limited aspects of movement, constrained by human strength and availability. In contrast, TEPI leverages robotics to augment the therapist’s capacity, delivering whole-body gait training that adjusts fluidly to the patient’s evolving performance. The hands-on adaptability of therapists is thus preserved but enhanced with robotic precision and scalability, facilitating more comprehensive, sustained walking practice without requiring multiple caregivers.
The core engineering breakthrough enabling TEPI is a control framework that models the mechanical interaction between therapist and patient exoskeletons as a coupled spring-damper system. This design imparts compliance and responsiveness, harmonizing the biomechanical inputs from both participants while preventing unnatural or jarring forces. By embedding this interactive virtual linkage, TEPI provides continuous haptic feedback to therapists, allowing them to modulate support, resistance, and corrective assistance in tune with patient movement intentions.
In a recent clinical evaluation published in Science Robotics, TEPI demonstrated superior outcomes compared to conventional therapist-guided treadmill training. Stroke survivors using the system achieved significantly greater joint range of motion, executed longer and higher stepping patterns, and maintained muscle activation at levels comparable to or exceeding standard therapy regimes. Importantly, patient motivation and enjoyment remained consistently high, underlining the system’s potential to foster engagement and adherence during demanding rehabilitation processes.
The TEPI platform addresses prominent limitations of current rehabilitation exoskeletons, many of which rely on rigid, preprogrammed gait cycles that lack real-time adaptability. By contrast, TEPI integrates therapist expertise directly into the robotic control loop, enabling instantaneous behavioral adjustments that match the patient’s unique recovery trajectory. This synergy of human judgment and machine assistance embodies a new paradigm in rehabilitation robotics, where technology serves to amplify, not replace, therapeutic skill.
José L. Pons, the project’s visionary leader and a professor at Northwestern, emphasizes that TEPI’s promise lies in its ability to unify the therapeutic closeness of manual training with the replicability and intensity of robotic interventions. Such hybrid systems are poised to transform stroke recovery protocols by bridging gaps between efficacy, accessibility, and individualized care. They not only alleviate therapist physical burden but also enhance the precision and personalization of rehabilitation exercises.
The development team included multidisciplinary experts spanning mechanical engineering, physical medicine, biomedical engineering, and robotics, fostering innovation at the interface of human-machine interaction and clinical practice. This collaboration ensured that TEPI’s control algorithms and mechanical design were continuously refined based on real-world clinical feedback, resulting in a system deeply attuned to both biomechanical and therapeutic demands.
Looking ahead, the research group plans to expand TEPI’s application beyond treadmill walking, exploring its integration into functionally critical daily activities such as overground ambulation, stair climbing, and sit-to-stand transitions. Longitudinal studies are also underway to assess the benefits of repeated therapy sessions over extended recovery periods. Additionally, efforts are progressing to miniaturize and streamline the technology for potential deployment in home environments, promising scalable remote rehabilitation solutions that can transcend geographic and logistical barriers.
TEPI’s pioneering approach was made possible by funding from the U.S. National Science Foundation’s National Robotics Initiative, reflecting the strategic importance of robotics in advancing healthcare outcomes. By embedding robotic exoskeletons within a responsive therapeutic framework, the system exemplifies how cutting-edge engineering can catalyze transformative changes in the treatment of neurological impairments.
This breakthrough not only advances rehabilitation science but also redefines the human role in therapy. TEPI empowers therapists to become active collaborators with their patients through enhanced, augmented physical connection, promoting a more effective and responsive recovery journey for stroke survivors. It stands as a shining example of innovation that is as empathetic as it is technological — a true step forward in restoring mobility and quality of life.
Subject of Research:
Robotic exoskeleton-assisted gait therapy for stroke rehabilitation through therapist-patient real-time interaction.
Article Title:
Therapist-exoskeleton-patient interaction for gait therapy
In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have emerged primarily as breakthrough medications targeting metabolic disorders such as type 2 diabetes and obesity. Medications like Ozempic and Wegovy have revolutionized treatment protocols by improving glycemic control and promoting weight loss through mechanisms involving appetite regulation and insulin modulation. However, intriguing new research spearheaded by scientists at Rutgers University suggests that the influence of GLP-1 receptor agonists may extend well beyond metabolic pathways, potentially modulating complex behaviors associated with violence and aggression.
The Rutgers study, published in the esteemed journal Criminology, delves into the behavioral ramifications of GLP-1 receptor agonist usage among adults in the United States. This groundbreaking investigation focused on whether these medications could attenuate the well-documented links between impulsivity, alcohol consumption, and violent behavior—an intersection of psychological and physiological domains rarely explored in pharmacological research. Given the increasing prevalence of GLP-1 usage, understanding these potential secondary effects holds substantial public health significance.
Researchers employed data gathered from a 2025 nationwide survey encompassing over 7,500 U.S. adults, narrowing their primary analysis to a subgroup of 821 individuals who had a history of GLP-1 medication use. This cohort was meticulously categorized into current versus former users to discern if ongoing GLP-1 receptor activity correlates with measurable differences in violent behavior frequency. Violent behavior metrics were derived from validated self-reported scales encompassing acts ranging from physical fights and assaults to more severe offenses like robbery, allowing for a comprehensive behavioral profile aligned with criminological standards.
A pivotal discovery from the analysis was the pronounced moderation of the relationship between impulsivity and violent conduct among current GLP-1 users. The data revealed that the association strength between impulsivity—a critical psychological trait linked to poor decision-making and aggression—and violent actions was reduced by approximately 62% in active GLP-1 users compared to those who had discontinued use. Such a substantial attenuation suggests that GLP-1 receptor agonists may exert neurobehavioral effects that temper impulsive drives which frequently precipitate violent acts.
Complementing these results, the study also examined the interplay between alcohol consumption, impulsivity, and violence. Alcohol’s role as a disinhibitor and amplifier of aggressive tendencies is well established. Among current GLP-1 medication users, the correlation between alcohol intake and violent behavior was notably diminished, showing around a 52% reduction in association strength relative to former users. While these findings were somewhat less consistent across different analytic models, they broadly indicate that GLP-1 receptor agonists might mitigate alcohol’s exacerbation of violent impulses, potentially via neurochemical or systemic pathways that modulate inhibitory control.
The underlying neural mechanisms posited by researchers revolve around the interplay of GLP-1 receptor activation within the central nervous system. GLP-1 receptors are expressed not only peripherally but also in brain regions implicated in impulse control, reward processing, and executive functions, such as the prefrontal cortex and limbic structures. Activation of these receptors could conceivably influence neurotransmitter systems including dopamine and serotonin pathways, which are integral to regulating mood, impulse control, and aggression. This neuropharmacological modulation may resemble cognitive behavioral therapy in effect — attenuating the translation of impulsive urges into violent actions without necessarily eradicating impulsivity itself.
Daniel Semenza, lead author and director of research at the New Jersey Gun Violence Research Center, underscored the public safety implications of these findings. With GLP-1 drugs increasingly prescribed globally, it is paramount to deepen scientific understanding of their broader psychobehavioral consequences. Exploring how these medications might serve dual roles in metabolic regulation and behavioral modulation opens new vistas in the multidisciplinary fields of medicine, psychology, and criminology. Such knowledge could inform clinical decisions and policies aimed at reducing violence, a persistent societal challenge with profound public health ramifications.
Nevertheless, the authors caution that the study’s observational, cross-sectional nature precludes definitive causal inferences. While associations are compelling, longitudinal and experimental research designs are essential to elucidate temporal dynamics and confirm whether GLP-1 receptor agonists actively reduce violence risk or if the observed correlations reflect confounding factors. Future studies integrating neuroimaging, pharmacokinetics, and behavioral assessments could unravel the precise biological and psychological pathways mediating these effects.
Christopher Thomas, coauthor and assistant professor at Rutgers University-Camden, highlighted the similarity between the behavioral influences observed and therapeutic interventions like cognitive behavioral therapy. Such parallels suggest that GLP-1 receptor agonists may have untapped potential as adjunctive treatments for impulse control disorders or behavioral problems characterized by aggression. Their dual metabolic and psychobehavioral actions could redefine therapeutic strategies for complex patients with overlapping physiological and psychiatric needs.
Moreover, understanding these effects could broaden the scope of violence prevention frameworks. If GLP-1 receptor agonists contribute to weaker links between impulsivity, substance use, and violent behavior, integrating pharmacotherapy with social and psychological interventions might amplify public safety outcomes. This intersection of neurobiology and criminology exemplifies the innovative, interdisciplinary research needed to address entrenched societal issues.
In summary, the Rutgers study furnishes compelling preliminary evidence that GLP-1 receptor agonist medications, beyond their established metabolic benefits, may significantly dampen the behavioral pathways leading from impulsivity and alcohol consumption to violence. These findings urge a paradigm shift toward holistic evaluation of drug effects encompassing neural, behavioral, and social domains. As the prescribing landscape for GLP-1 medications continues to expand, vigilant research and nuanced understanding will be critical to harnessing their full therapeutic potential while safeguarding public health.
Subject of Research: People Article Title: GLP-1 receptor agonist use and violent crime among US adults News Publication Date: 17-Jun-2026 Keywords: Violence, Drug therapy, Weight loss, Mental health
In a groundbreaking study published in PNAS Nexus on May 23, 2026, researchers have unveiled compelling evidence that extreme risk protection orders (ERPOs), frequently known as “red flag” laws, substantially diminish the likelihood of arrests among individuals subjected to these legal interventions. This decline in arrests encompasses a broad spectrum of offenses, notably violent crimes and firearm-related offenses, and persists not only during the enforcement period of the orders but intriguingly continues well beyond their expiration. These findings are poised to reshape public policy discussions concerning firearm violence prevention strategies in the United States.
The context driving this research is a nationwide crisis of firearm violence, which as of 2024, has tragically culminated in over 43,000 deaths, with shootings in 2025 alone injuring approximately 40,000 individuals, excluding cases of suicide. Such staggering figures underscore the urgent need for efficacious interventions. ERPOs have emerged as a targeted legal mechanism whereby courts temporarily restrict firearm access for individuals deemed to pose an imminent threat to themselves or others. Currently, 22 states, alongside the U.S. Virgin Islands and the District of Columbia, have enacted distinct ERPO statutes, reflecting growing legislative momentum. California pioneered this policy approach in 2016, branding them Gun Violence Restraining Orders.
The retrospective cohort study analyzed detailed arrest data from 679 California residents subject to ERPOs between 2016 and 2019. Demographic profiling revealed a predominance of males (91.9%) with an average age slightly above 40 years. Ethnically, the cohort comprised mainly White individuals (59.9%), followed by Hispanic (19%) and Black populations (10.3%). Researchers meticulously compared arrest rates across three critical intervals: six months preceding the ERPO issuance, during the active order period, and the subsequent six months following order expiry. The scope of offenses under scrutiny included any form of arrest, violent crime, firearm-related offenses, and firearm-specific violence.
Quantitative analysis revealed that the presence of an ERPO corresponded with an impressive 55% reduction in arrests for any offense compared to the baseline six-month period prior. Arrests specifically for violent crimes plummeted by 71%, while firearm-related arrests witnessed a striking 76% decline. Most notably, firearm violence arrests decreased by an extraordinary 80% during the enforcement phase. These statistics not only affirm ERPOs’ immediate efficacy in curtailing dangerous behaviors but also highlight their targeted protective potential.
Perhaps more unexpectedly, the data indicated that the downward trend in arrests did not revert to pre-order levels once ERPOs expired. Instead, reductions persisted and even deepened in certain categories. Post-expiration, arrest rates for any offense decreased by 63%, violent crime arrests by 75%, firearm-related offenses by 70%, and firearm violence arrests by 63%. Such sustained effects provoke critical questions about the mechanisms through which ERPOs might exert enduring behavioral influence, potentially functioning as a catalyst for long-term risk amelioration.
While the study’s outcomes exude optimism, authors elucidate several methodological limitations. Primary among these is the reliance on arrest records as a proxy for criminal activity, a metric subject to inherent biases and imperfect capture of all unlawful behavior. Additionally, the exclusive focus on California’s ERPO implementation during a specific timeframe limits the generalizability of findings to other jurisdictions or more current contexts. Nonetheless, the robust statistical associations discovered furnish key empirical support for ERPOs’ role in comprehensive violence reduction frameworks.
Veronica Pear, the study’s lead investigator and a respected epidemiologist affiliated with the UC Davis Centers for Violence Prevention, articulates the multipronged utility of ERPOs. “While often conceptualized primarily for suicide prevention, our analysis elucidates their significant function in preventing interpersonal violence,” Pear asserts. This research thus broadens the conceptual paradigm, reinforcing ERPOs as a practical, evidence-based intervention capable of mitigating acute crises and producing enduring safety benefits.
This study also complements a growing body of literature that underscores ERPOs as instrumental in suicide prevention, consolidating their standing as a versatile tool in public health and criminal justice spheres. The convergence of findings across domains of self-directed and other-directed violence lends vital credence to expanding ERPO adoption and refining enforcement protocols, especially given the current societal imperative to stem firearm-related morbidity and mortality.
From a policy perspective, these insights furnish lawmakers with empirically grounded justifications for instituting or strengthening ERPO frameworks. Importantly, the study encourages a nuanced appreciation of ERPOs’ temporal dynamics, highlighting the necessity for continued engagement and perhaps supplemental interventions after an order lapses to sustain positive outcomes.
On the frontier of violence prevention research, the study paves avenues for further investigation into optimizing ERPO implementation, exploring differential impacts across demographic subgroups, and elucidating the behavioral psychology underlying observed arrest reductions. Such endeavors will be pivotal in tailoring ERPO policies that maximize protective effects while respecting individual rights and legal safeguards.
As firearm violence continues to exact a heavy toll on American communities, this research provides a beacon of evidence-informed hope. By harnessing the nuanced potential of ERPOs, stakeholders can better navigate the complex interplay of legal, public health, and social factors driving violence prevention and move toward a safer society.
Subject of Research: People
Article Title: Reduced incidence of arrest following an extreme risk protection order among respondents in California
Pear, V., et al. (2026). Reduced incidence of arrest following an extreme risk protection order among respondents in California. PNAS Nexus. DOI: 10.1093/pnasnexus/pgag184
Keywords: Gun violence, Public health, Crime, Criminology, Human social behavior
In the mountain villages of Guatemala’s Western Highlands, farmers are combining ancient Maya knowledge with modern sustainable farming techniques to protect their crops from pests and disease. Smallholders are creating homemade biopesticides using plants with strong smells and flavors to deter pests on their family plots. This is helping to cut back on the use of increasingly expensive agrochemicals, many of which have been labeled as dangerous to human health and linked to soil degradation. About 60 Guatemalan communities in the Western Highland departments of Sololá and Huehuetenango, as well as Chiquimula in the east, are working to revive these traditional techniques with support from the international development organization World Neighbors. Their focus is to restore and strengthen traditional knowledge, combining it with agroecological practices that help families produce surplus food they can sell to boost household incomes. “Traditional farming techniques are becoming popular because they are simple practices to apply, use local resources, and have proven to be effective,” Dayani Roche, a program associate at World Neighbors, told Mongabay via email. Rather than a single ancient recipe, farmers are using “a living combination of ancestral knowledge, local experimentation and more recent agroecological practices,” he said, which are “safer for families, soil, water and biodiversity than many chemical alternatives.” The Maya civilization, which once stretched across modern-day Central America, had a rich history of farming dating back to 2000 B.C.E. Its most celebrated agriculture system is the milpa, a form of intercropping that involves a mix of maize, beans and…This article was originally published on Mongabay
Login
